Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Companyâ€™s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

05/11 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26/26/26	SEK 0.1834	-1.93%	7,87,885
23/26/23	SEK 0.1870	+2.75%	10,15,475
22/26/22	SEK 0.1820	-5.41%	8,45,980
21/26/21	SEK 0.1924	+0.31%	11,06,095
20/26/20	SEK 0.1918	-1.74%	5,21,202

Delayed Quote Nasdaq Stockholm

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Acarix AB

Company calendar

Delayed Nasdaq Stockholm 08:02:26 26/10/2026 pm IST			5-day change	1st Jan Change
0.1834 ^SEK	-1.93%		-6.05%	-31.57%

19/10	Acarix Wins Saudi Regulatory Nod for Coronary Artery Disease Detection Device	MT
19/10	Acarix AB Receives Regulatory Approval In Saudi Arabia	CI

Market Cap	23Cr 2.34Cr 2.09Cr 1.93Cr 1.75Cr 3.27Cr 221.83Cr 3.32Cr 9.18Cr 116.22Cr 8.77Cr 8.58Cr 366.42Cr	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	23Cr 2.34Cr 2.09Cr 1.93Cr 1.75Cr 3.27Cr 221.83Cr 3.32Cr 9.18Cr 116.22Cr 8.77Cr 8.58Cr 366.42Cr	EV / Sales 2026 *	16.6x	EV / Sales 2027 *	7.25x
Free-Float	89.13%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Nasdaq Stockholm	ACARIX	Delayed
OTC Markets	ACIXF	Delayed
Deutsche Boerse AG	7AC	Delayed
CBOE		Real-time
CBOE		Real-time

19/10	Acarix Wins Saudi Regulatory Nod for Coronary Artery Disease Detection Device	MT
19/10	Acarix AB Receives Regulatory Approval In Saudi Arabia	CI
24/09	25 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
17/09	Nine stocks have so far today hit new 52-week lows on the Stockholm stock exchange	FW
11/09	Acarix Publishes Peer-Reviewed Study Confirming CADScor System Diagnoses Heart Failure With Fewer False Positives Than Standard Blood Test	CI
14/08	Acarix AB, Q2 2026 Earnings Call, Aug 13, 2026
13/08	Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
13/08	Calendar for Thursday, August 13	FW
10/08	Acarix Receives Regulatory Approval For The CADScor System In The UAE	CI
10/08	Acarix Receives UAE Clearance for Point-of-Care Diagnostic Aid	MT
18/06	Acarix AB Announces Directorate Appointments	CI
16/06	Acarix AB Announces That Marlou Janssen-Counott Declines Re-Election as A Member of the Board of Directors	CI
12/06	Calendar Monday June 15 - Friday June 19	FW

Acarix AB Share Price

Stocks

ACARIX

SE0009268717

Advanced Medical Equipment & Technology

Valuation: Acarix AB

Chart: Acarix AB

Latest news: Acarix AB

Last Transcript: Acarix AB

Analysts' recommendations: Acarix AB

Press Releases: Acarix AB

Quotes and Performance

Price Extremes

Managers and Directors: Acarix AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

19/10	Acarix : receives Regulatory Approval in Saudi Arabia.	PU
08/10	Acarix Provides Update on RHTP and Saudi Arabia Regulatory Process	AQ
14/09	Acarix: Seismocardiography gains further validation in heart failure	AQ
11/09	Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test	AQ
17/08	Acarix (Q2 Review): Laying the groundwork	AQ

1 day	-1.93%
1 week	-6.05%
Current month	-5.37%
1 month	-1.71%
3 months	-25.75%
6 months	-37.30%
Current year	-31.57%

1 week	0.18	0.2
1 month	0.18	0.24
Current year	0.18	0.33
1 year	0.18	0.34
3 years	0.17	0.6
5 years	0.17	1.47
10 years	0.17	26.8

Manager	Title	Age	Since
Aamir Mahmood CEO	Chief Executive Officer	-	01/02/2024
Christian Lindholm CEO	Chief Executive Officer	62	23/02/2018

Director	Title	Age	Since
Louise Janssen-Counotte BRD	Director/Board Member	61	01/01/2020
Kenneth Nelson BRD	Director/Board Member	52	14/05/2024
Tony Das BRD	Director/Board Member	-	14/05/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACARIX AB	-1.93%	-6.05%	-32.57%	-18.85%	2.34Cr
THERMO FISHER SCIENTIFIC, INC.	+1.31%	+0.60%	+21.22%	+55.27%	25TCr
DANAHER CORPORATION	+1.28%	+4.03%	+5.64%	+20.55%	16TCr
INTUITIVE SURGICAL, INC.	+0.88%	+5.12%	-17.40%	+75.47%	16TCr
BOSTON SCIENTIFIC CORPORATION	-0.33%	+1.07%	-55.55%	-8.54%	6.62TCr
VEEVA SYSTEMS INC.	+0.24%	+2.43%	+9.75%	+70.67%	5.23TCr
SIEMENS HEALTHINEERS AG	+0.78%	+2.68%	-14.85%	-8.63%	5.22TCr
EDWARDS LIFESCIENCES CORPORATION	+1.04%	+3.31%	+11.49%	+43.53%	5.13TCr
AGILENT TECHNOLOGIES, INC.	+1.59%	+3.92%	+20.45%	+69.27%	4.88TCr
WATERS CORPORATION	+1.45%	+5.96%	+30.82%	+88.24%	4.46TCr
Average	+0.60%	+1.93%	-2.10%	+38.70%	8.84TCr
Weighted average by Cap.	+0.99%	+1.40%	+2.82%	+46.59%

	2026 *	2027 *
Net sales	1.4Cr 14.1L 12.59L 11.63L 10.54L 19.72L 13Cr 20.05L 55.43L 7.01Cr 52.93L 51.8L 22Cr	3.2Cr 32.23L 28.79L 26.59L 24.1L 45.08L 31Cr 45.83L 1.27Cr 16Cr 1.21Cr 1.18Cr 51Cr
Net income	-3.08Cr -31.03L -27.71L -25.59L -23.19L -43.39L -29Cr -44.11L -1.22Cr -15Cr -1.16Cr -1.14Cr -49Cr	-1.53Cr -15.41L -13.76L -12.71L -11.52L -21.56L -15Cr -21.91L -60.57L -7.67Cr -57.84L -56.61L -24Cr
Net Debt	-	-